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Abstract
Background: The goal of the present study was to develop an in vitro choroid plexus (CP)
epithelial cell culture model for studying transport of protein-mediated drug secretion from blood
to cerebrospinal fluid (CSF) and vice versa.
Methods: Cells were isolated by mechanical and enzymatic treatment of freshly isolated porcine
plexus tissue. Epithelial cell monolayers were grown and CSF secretion and transepithelial
resistance were determined. The expression of f-actin as well as the choroid plexus marker protein
transthyretin (TTR), were assessed. The expression of the export proteins p-glycoprotein (Pgp,
Abcb1) and multidrug resistance protein 1 (Mrp1, Abcc1) was studied by RT-PCR, Western-blot
and immunofluorescence techniques and their functional activity was assessed by transport and
uptake experiments.
Results: Choroid plexus epithelial cells were isolated in high purity and grown to form confluent
monolayers. Filter-grown monolayers displayed transendothelial resistance (TEER) values in the
range of 100 to 150 Ωcm2. Morphologically, the cells showed the typical net work of f-actin and
expressed TTR at a high rate. The cultured cells were able to secrete CSF at a rate of 48.2 ± 4.6
μl/cm2/h over 2–3 hours. The ABC-export protein Mrp1 was expressed in the basolateral (blood-
facing) membranes of cell monolayers and intact tissue. P-glycoprotein showed only low expression
within the apical (CSF directed) membrane but was located more in sub-apical cell compartments.
This finding was paralleled by the lack of directed excretion of p-glycoprotein substrates, verapamil
and rhodamine 123.
Conclusion: It was demonstrated that CP epithelium can be isolated and cultured, with cells
growing into intact monolayers, fully differentiating and with properties resembling the tissue in
vivo. Thus, the established primary porcine CP model, allowing investigation of complex transport
processes, can be used as a reliable tool for analysis of xenobiotic transport across the blood-
cerebrospinal fluid barrier (BCSFB).
Background
The brain is very sensitive to changes in its surrounding
environment and homeostasis is essential to maintain
normal function. Separated from the vascular system,
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most water-soluble compounds are excluded for stability
and protection. Furthermore, endogenous metabolites as
well as xenobiotics are actively removed from the CNS.
Anatomically, three structures separate brain and blood
flow: The network of brain capillaries or blood-brain bar-
rier (BBB), the choroid plexus (CP) or blood-CSF barrier
(BCSFB) and the arachnoid membrane. Both, the BBB and
the BCSFB actively regulate type and concentration of
molecules transported to and from the brain extracellular
fluid, CSF and intracellular fluid.
The CP bears a resemblance to the renal proximal tubules
in its epithelial ultrastructure and, like the kidney, trans-
ports near isotonic fluid across its epithelium [1]. Analo-
gous to the kidney which functions to stabilize the
chemical composition of blood, the CP is responsible for
stability of the CSF. However, instead of acting as a filter,
CSF is actively produced within the CP and enriched with
nutrients derived from the blood. Bulk movement of fluid
and molecules takes place from blood to CSF, across the
infolded basolateral membrane and tightly packed villi at
the apical membrane. However, movement may also
occur in the opposite direction, with apical villi acting as
a filter by secreting compounds and metabolites into the
vascular system for eventual elimination by liver or kid-
ney.
One of the most important CP functions is CSF secretion
[2]. In man, its total volume is renewed every 4 to 5 h,
with 90% of CSF produced by CP tissue [3]. The CP, with
its array of metabolizing enzymes and coupled transepi-
thelial vectorial efflux of conjugated metabolites into the
blood, is an effective detoxification system within the
brain [4]. In fact, the CP is one of the main sites of xeno-
biotic metabolism in the brain [5].
Many compounds are transported across the CP epithe-
lium and to date, a total of eleven transporter families
with almost 30 individual transport proteins, of which 13
are expressed at moderate to high levels, are found in the
CP [6]. However, many are expressed at low levels and
only eight are localized to specific membranes. The trans-
porters are members of the solute carrier family (SLC) and
of the active and energy consuming ATP-binding cassette
(ABC) transporter family.
Several in vivo and in vitro techniques and models have
been used to study transport across the CP [7]. In vivo tech-
niques require elaborate experimental procedures and
surgical skills. Common methods include the serial sam-
pling of CSF, following drug administration, and decon-
volution of data to determine transport profiles. Isolated
tissue is used in extracorporal perfusion studies or for in
situ chamber isolations of CP. In vitro methods include
primary culture of isolated choroid plexus epithelial cells
(CPEC), from a variety of different species, or culture of
immortalized epithelial cells. Both primary and cell line
CPEC cultures develop an impermeable monolayer and
display the characteristics of CPEC in vivo.
Different approaches have been developed to establish a
CPEC in vitro model. Crook et al in 1981 were the first to
publish a protocol on epithelial cell isolation and cultiva-
tion using CP cells from bovine brains [8]. Other species
used thereafter include rabbit [9,10], rat [11-13] and pig
[14]. Typically, CP tissue is removed from lateral ventri-
cles and mechanically fractionated. Individual CPs are
digested using proteolytic enzymes, such as trypsin, pro-
nase, collagenase and also DNAse, yielding an isolate of
epithelial cells.
Here, we present a comprehensive functional characteri-
zation of an in vitro cell culture model, derived from por-
cine CP epithelial cells. In addition to investigation of
features, such as marker protein expression, CSF secretion
and enzyme function, special attention is directed towards
the ABC transport proteins p-glycoprotein (Pgp) and mul-
tifunctional resistance protein 1 (Mrp1).
Methods
Tissue
Freshly isolated porcine brains were obtained from the
local slaughterhouse (Fleischversorgungszentrum Man-
nheim, FRG).
Isolation and culture of porcine CP epithelial cells
Epithelial cells from porcine CP were prepared as
described previously with modifications [14]: Freshly iso-
lated CP tissue was incubated with 0.25% (w/v) trypsin
solution (Biochrom, Berlin, FRG) for 2.5 h at 4°C and
then for an additional 0.5 h at 37°C. Proteolytic activity
was terminated by addition of newborn calf serum (Bio-
chrom, Berlin FRG). Remaining tissue was removed and
the cell suspension was centrifuged at 1000 × g for 10 min.
The cell pellet was resuspended in DMEM/HAM's F12
(1:1) (Bioconcept, Freiburg, FRG) supplemented with
10% (v/v) fetal calf serum (FCS), 4 mM L-glutamine, 5 μg/
ml insulin, 200 ng/ml hydrocortisone, 5 ng/ml sodium
selenite, 20 μM cytosine arabinoside, 100 g/ml penicillin/
streptomycin and 10 ng/ml epidermal growth factor. Cells
were seeded either on laminin-coated (50 μg/ml in water)
Transwell®  filter membranes (Costar, Cambridge MA,
USA) or flasks. The seeding density was adjusted that 1 g
of tissue covered an area of 50 cm2. Twenty-four hours
after plating, the cultures were washed with PBS (1 mM
Ca2+, 0.5 mM Mg2+) to remove red blood cells. The
medium was changed three times a week. FCS was
removed after 9 days in culture (DIC).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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Total RNA isolation
Fresh tissue samples were stored in ice cold RNALater®
(Sigma, Steinheim, FRG) for transport in the time frame
allowed by RNALater® (max. 1 h) and frozen at -70°C
upon arrival. Cultured CPEC were washed in KRB, pH 7.4,
at 37°C three times to remove all remaining medium,
before starting RNA isolation procedures. Total RNA from
fresh and cultured CPEC was isolated according to the
Qiagen RNeasy® (Qiagen, Mannheim, FRG) protocol. Tis-
sues or cells cultured in flasks were lysed in β-mercap-
toethanol containing RLT buffer according to the Qiagen
tissue and cell lysis protocols. An equal volume of 70%
EtOH was added and samples were transferred to supplied
spin columns. Following the Qiagen wash and spin regi-
men, total RNA was eluted in a small volume of nuclease
free water. The amount of isolated RNA was quantified
photometrically, measuring OD at 260 nm, with OD of 1
corresponding to 40 μg of single stranded RNA [15].
Purity was further established by taking the OD ratio of
260 nm over 280 nm. Only samples with a ratio of 1.7 to
2.0 were used, as low ratios are characteristic of protein
and high ratios of residual β-mercaptoethanol contamina-
tion.
Isolation and culture of porcine brain capillary endothelial 
cells
Brain capillary endothelial cells were isolated and cul-
tured and permeability experiments were performed as
described in our previous publication [16].
Reverse Transcription
Reverse transcription (RT) was carried out according to
the Promega Reverse Transcription System®  (Promega,
Mannheim, FRG). One μg of total RNA was incubated at
70°C for 10 min and after adding the reaction mixture (in
20 μl: 4 μl 25 mM MgCl2, 4 μl 5X transcription buffer, 2
μl 10 mM dNTP mixture, 0.5 μl RNAsin® ribonuclease
inhibitor, 0.5 μg oligo(dT)15 primer and nuclease free
water) containing 5 units of avian myeloblastosis virus
reverse transcriptase (AMV-RT), was further incubated at
42°C for 60 min. Resulting cDNA was either used directly
in further reactions or frozen at -20°C.
Polymerase Chain Reaction (PCR)
The PCR reaction was used to amplify selective regions of
generated cDNA. For each PCR reaction, 10 to 100% of
the cDNA generated from 1 μg total RNA was used. All
reactions were carried out using a hot-start protocol [17]
in order to maximize sensitivity and specificity. The sam-
ples were run for a total of 15 to 50 cycles. Finally, PCR
products were separated in a 1.5% ethidium bromide
stained agarose gel and visualized under UV-light. All
primers used are listed in Table 1.
Semi-Quantitative RT-PCR
β-Actin expression was used as internal standard. Total
RNA was isolated and transcribed, and selective regions
amplified as described above. Density readings of ethid-
ium bromide-stained PCR products were obtained, using
the Scion Image software (NIH, USA), and normalized in
relation to β-actin. To determine the phase of linear
amplification, a series of amplifications in five-cycle inter-
vals was run. A range of concentrations was amplified to
ensure that results were not affected by initial amounts of
mRNA and cDNA in any particular sample.
Protein determinations
Total protein concentration was determined according to
Bradford [18].
Enzyme activities
Akaline phosphatase and γ-glutamyl transferase activities
were measured according to the Sigma (Munich, FRG)
protocol and to Caspers and Diglio [19]. Both enzymes
were used as marker enzymes for the apical plasma mem-
branes of CP epithelial cells.
Immunocytological staining
CPEC were fixed in 95% EtOH for 15 min at room tem-
perature. Cells were permeated with 0.1% Triton X-100
for 15 min. Specimens were then blocked in blocking
buffer (1% BSA and 1% milk powder) for 1 h, before incu-
bation with target antibody at a dilution of 1:10 in block-
ing buffer at room temperature overnight. After washing,
samples were incubated with a FITC-labeled secondary
Table 1: Primer Nucleotide Sequences.
Target* Accession Number Forward Primer Reverse Primer Product (bp)
transthyretin (TTR, prealbumin) X87846 TGGTCAAAGTCCTGGATGCT
TTACATGCAAGCCTGTCCCT
371
β-actin U07786 TTTGAGACCTTCAACACGCC
TGATCCACATCTGCTGGAAG
703
Mrp1 L05628 TTCGTTCTCAGGCACATCAATG
AACACAAGGATCTTCGTCTTCCTC
436
Pgp AF016535 GAGAGGGGCCCAGTTGAGTG
CACAAGCCCAAGACAGAAAGC
468
*Derived from porcine sequences if possible, if not human sequences (Mrp1, Pgp) were used.Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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IgG (Dako, Glostrup, DK) for 2 h at 1:100 in blocking
buffer, with 10 μM propidium iodide (PI) added. For con-
trols, the primary antibody was omitted. F-actin-stained
cultured CPEC were incubated with 10 μM phalloidin-
FITC and 10 μM PI or with PI only for treatment and con-
trol, respectively. Samples were embedded in Aqua Poly-
mount®  (Polysciences Inc., Warrington, PA, USA) and
viewed through an inverted Leica DM-IRB confocal micro-
scope, using a 40× oil immersion objective (NA 1.2), a
488-nm argon ion laser excitation and a 500-nm long-
pass emission filter.
Isolation of apical and basolateral membrane fractions
Methods for CPEC membrane fraction isolation were
adapted from a protocol for kidney membranes [20].
Freshly isolated lateral CP was homogenized in homoge-
nizing solution (HS, in mM: 300 mannitol, 0.1 phenyl-
methylsulfonyl fluoride, 1 EDTA and 18 Tris HCl, pH
7.5), using 6 g CP tissue per 50 ml HS. The homogenate
was centrifuged at 3,000 g(max) for 10 min. MgCl2(1 M at
1 % of volume) was added to the resulting supernatant
(S1) and stirred for 20 min on ice. The solution was then
centrifuged at 2,000 g(max) for 10 min. The resulting super-
natant (S2) was used for isolation of apical membrane
fractions and resulting pellet (P2) for the isolation of
basolateral membrane fractions.
For the isolation of apical membrane fractions, S2 was
centrifuged at 33,000 g(max) for 20 min. The pellet was
resuspended in half the original volume of HS, and 1 M
MgCl2 was added to arrive at a concentration of 10 mM
MgCl2. After 20 min on ice, the solution was centrifuged
at 4,350 g(max) for 12 min and the pellet discarded. This
procedure was repeated twice. Finally, the solution was
centrifuged at 6400 g(max) for 12 min, the pellet discarded
and the supernatant further centrifuged at 32,900 g(max)
for 20 min. The resulting pellet was the apical membrane
fraction. Basolateral membrane fractions were obtained
by resuspending P2 in HS and centrifuging at 48,300
g(max) for 20 min. This procedure was repeated twice. Then
the pellet was resuspended in a small volume of HS and
mixed with 2 ml Percoll per 10 ml. The mixture was cen-
trifuged 48,300 g(max) for 30 min, after which two layers
became evident. The upper layer was removed and
remaining Percoll washed out by adding an excess
amount of PBS (without magnesium and calcium) and
centrifuging at 48,300 g(max) for 30 min. The pellet was
taken up in HS. Both membrane fractions were character-
ized, the apical by analysis of alkaline phosphatase and γ-
glutamyl transferase activity, the basolateral by determi-
nation of Mrp1 expression in Western blot analysis.
Western Blots
CPEC whole cell protein samples or enriched membrane
fractions were studied by Western blot analysis according
to Sambrook et al [15]. Proteins were denatured in a SDS-
containing sample buffer (100 mM Tris-HCl (pH 6.8), 4%
SDS, 2% bromophenol blue, 20% glycerol) and reduced
using either β-mercaptoethanol or D,L-dithiothreitol.
Protein samples were heated to 95°C or 60°C for 10 min
or 5 min for analysis of marker proteins or ABC-transport-
ers, respectively. Following SDS-PAGE (15 to 6% polyacr-
ylamide gels) at 80 V for 2 h in running buffer (25 mM tris
(pH 8.3), 250 mM glycine, 0.1% SDS), samples were blot-
ted on nitrocellulose at 250 mA for 2.5 h in blotting buffer
(39 mM glycine, 48 mM tris-base (pH 8.3), 0.037% SDS,
20% methanol). After 1 h blocking, samples were incu-
bated with target antibody at a dilution of 1:100 in block-
ing buffer at 4°C overnight, followed by incubation in
horseradish peroxidase (HRP)-labeled secondary IgG
(DakoCytomation) at a dilution of 1:1,000 in blocking
buffer for 2 h. The resulting bands were visualized with
diaminobenzidine in combination with NiCl2. Porcine
brain capillary endothelial cells, liver and kidney samples
were used as positive controls.
CPEC Cerebrospinal-Fluid Secretion
To assess CSF secretion by cultured CPEC, cells were cul-
tured on permeable, polyester six-well Transwell® filter
plates coated with 5 μg/ml laminin for 13 to 15 DIC. Cells
were washed three times in CSF secretion buffer (CSFB, in
mM: 122 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2, 15 Na-HCO3, 15
HEPES, 0.5 Na2HPO4, 0.5 NaH2PO4 and 17.5 glucose, pH
7.3, 37°C, with 5 μg/ml insulin added [21]). Following a
1 h preincubation with CSFB, 1.0 ml 1.0 μM 67 kDa fluo-
rescent-dextran (FITC-dextran) in CSFB was added to both
apical and basolateral chambers and secreted CSF volume
(in μl/cm2) was calculated as a function of FITC-dextran
concentration change. Dextran at 67 kDa is suitable for
these measurements, as it was shown in separate experi-
ments to be impermeable to the cell monolayer.
Filters were incubated at 37°C, 5% CO2 and 95% relative
humidity for up to 8 h. 200 μl samples were taken on the
hour from either the apical or basolateral chamber and
replaced with fresh dextran solution. Samples were ana-
lyzed in a fluorescent plate reader (Ascent Fluoroscan, Oy,
Finland). CSF volumes secreted were corrected for the
sampling regime (for details on correction for sampling
regime see Hakvoort et al [21]) and then calculated
according to equation (1):
Where, VCSF = CSF volume [μl], CDex (initial) = initial
FITC-dextran concentration [μM], CDex (final) = final
FITC-dextran concentration [μM], V0  = initial volume
applied [μl].
V
CC
C
CSF
Dex initial Dex final
Dex final
=
−
× ()
() ( )
()
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Transepithelial Electrical Resistance (TEER)
TEER values were determined for CPEC grown on perme-
able polyester Costar Transwell® membranes, using the
Millicell®-ERS and STX-2 electrode system (World Preci-
sion Instruments, Berlin, FRG). Control values obtained
from coated filters without cells (blank) were subtracted
and the resulting values multiplied by the filter surface
area, resulting in TEER values of Ωcm2.
Permeability experiments
For paracellular permeability analysis, CPEC were grown
on Transwell® filter systems for 9 DIC in serum-containing
medium, followed by another 5 DIC in serum-free
medium. Marker compounds were applied from either
the apical or basolateral chamber and accumulation was
measured in the opposite compartment. All markers were
used at a concentration of 10 μM. Only filter systems
showing a TEER higher than 100 Ωcm2 (≈ 600 Ωcm2 fol-
lowing impedance analysis [22]) were used for permeabil-
ity experiments. The apparent permeability coefficients
were measured for 5-carboxyfluorescein (0.4 kDa) and
fluorescent-labeled dextrans between 4.4 kDa and 500
kDa in size, across CPEC 14 DIC monolayers, grown on
polyester membranes of 10 μM thickness, a pore size of
0.4  μm, and 4 × 106 pores per cm growth area. The
medium was exchanged with Krebs-Ringer buffer (KRB),
0.5 ml in the apical, 1.5 ml in the basolateral chamber,
and test compound added to the donor compartment at
the desired concentration. The plates were shaken at 100
rpm and 100 μl samples were taken after 15, 30, 45, and
60 min from the acceptor compartment and replaced with
fresh buffer. For inhibitor treatments, cells were pre-incu-
bated with inhibitor alone. For pre-incubation and for
transport measurements, inhibitors were added to both
apical and basolateral compartments.
The permeability coefficient P of test compounds was cal-
culated according to equation (2):
with dc/dt representing the change of the acceptor concen-
tration over time, Vacceptor the acceptor volume, A the mem-
brane surface area and c0 the initial donor concentration.
Concentrations were assessed by analysis in a fluorescent
plate reader (Ascent Fluoroscan) for fluorescent-labelled
compounds. When verapamil was used, tracer amounts of
[3H]-verapamil (NEN/Perkin-Elmer, Rodgau – Jügesheim,
FRG) were added, and the samples were analyzed by liq-
uid scintillation counting.
CP Uptake assays
Uptake assays were carried out with CPEC cultured in 96-
well plates. For all experiments CPEC were cultured for 13
DIC up to 15 DIC. Cells were washed three times and then
pre-incubated in KRB, pH 7.4, 37°C, for 30 min, without
(control) and with inhibitor added. After 90 min incuba-
tion with substrate or substrate and inhibitor for control
and treatment samples, respectively, cells were washed
five times with KRB, pH 7.4, 37°C, lysed in 1% Triton X-
100 and the wells analyzed in a fluorescent plate reader
(Ascent Fluoroscan). Wells containing CPEC incubated
with KRB only served as blank. Apparent uptake was cal-
culated by subtracting blanks from fluorescent values. Flu-
orescent values were quantified using an appropriate
standard curve.
Statistics
All values presented are means ± SEM. Control and treat-
ment groups were compared by either student's t-test or
one-way analysis of variance, followed by either a Bonfer-
roni or Dunnett's post hoc test. Differences were consid-
ered significant at *P < 0.05 and **P < 0.01. Regression
analysis was carried out to analyze appropriateness of
standard curves used and only linear relationships with an
R2-value greater than 0.95 were used for transformations.
Results
Cell isolation and culture
Porcine lateral CP isolated from brain and digested by
cold trypsination yielded 6.5 × 106 ± 5.2 × 105 viable cells/
g tissue (n = 25), using approximately 4.2 g tissue per
preparation. Following isolation, cells were seeded on
either Transwell® filter systems, 96-well plates or in culture
flasks at a seeding density of at least 1 g per 50 cm2 or 1.2
× 105 cells per cm2. In general, CPEC growth was slow and
proliferation rates were low. Addition of cytosine arabino-
side suppressed the growth of contaminating cells and
epithelial cell cultures developed into a monolayer within
nine DIC, displaying the typical cobblestone appearance.
After nine DIC, serum was removed from the medium and
CPEC monolayers allowed to fully differentiate for
another 4–5 days.
CP epithelial cell F-actin
Actin is most abundant in eukaryotic cells and highly con-
served. Actin filaments are associated with tight junctions
(TJ) and perijunctional actin is directly involved in con-
trolling paracellular permeability [23]. To visualize actin
distribution throughout the cultured cells, the protein was
stained with fluorescent-labeled phalloidin (FITC-phal-
loidin), which binds specifically to f-actin. Propidium
iodide (PI) was also added to permeated cells, staining
cell nuclei. Figure 1 shows an image of CPEC 14 DIC after
incubation with FITC-phalloidin and PI, visualized by
confocal laser scanning microscopy. Overall, cultured epi-
thelial cells appeared as a confluent monolayer. No unde-
sired and contaminating cells (e.g. fibroblasts or
macrophages) were present. All CPEC abundantly
P
dc
dt
V
Ac
acceptor =×
× ()
0
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expressed f-actin and, as expected from fully differentiated
cells, the stain revealed actin filaments in networks and
bundles, some of which spanned the whole cell.
Marker protein prealbumin (transthyretin, TTR)
In the mammalian brain, TTR is specifically localized to
the CP [24] and hence TTR is a convenient marker for
CPEC. The unpublished mRNA sequence for porcine spe-
cific TTR, accession number X87846, was submitted to the
Nucleotide Entrez database by Archibald et al [25]. For
TTR mRNA expression analysis, cells were grown for nine
DIC in serum-containing medium and allowed to fully
differentiate in serum-free medium for additional five
days. Figure 2A shows amplified cDNA of porcine liver
(control), fresh CP, CP 9 DIC and CP 14 DIC in an ethid-
ium bromide gel visualized under UV-light. TTR amplified
at 371 bp specific for TTR mRNA expression and is shown
in the top lanes. Fresh CP (0 DIC) TTR amplification pro-
duced gel bands after 15 amplification cycles. The signal
for cultured CPEC was less intense, with signals visible
after 25 amplification cycles. β-Actin amplified with simi-
lar intensity in all CPEC samples. Thus, TTR mRNA
expression was higher in fresh CP tissue when compared
to TTR expressed in cultured CPEC.
TTR protein expression was investigated in immunologi-
cal staining of cultured CPEC 14 DIC and in Western blot
analysis, using fresh and cultured CPEC 14 DIC. Figure 2B
shows confocal images of a cultured CPEC monolayer
stained with anti-TTR and PI. In cultured CPEC, TTR local-
ized throughout the cytoplasm, with most intense stain-
ing around the cell nuclei. Fewer signals were observed
towards the cell membrane.
Figure 2C shows the Western blot of the 55 kDa TTR dena-
tured to 15 kDa TTR fragments (monomer subunits) in
fresh CPEC and cultured cells 14 DIC. Porcine liver was
used as positive control. Samples without primary anti-
body incubation are included as negative control. All sam-
ples with primary antibody added show TTR staining.
FITC-Phalloidin-stained porcine choroid plexus epithelial  cells monolayer after 14 days cell culture (stained f-actin in  green, propidium iodide-stained cell nuclei in red) Figure 1
FITC-Phalloidin-stained porcine choroid plexus epithelial 
cells monolayer after 14 days cell culture (stained f-actin in 
green, propidium iodide-stained cell nuclei in red).
A) Amplified cDNA of liver (control), fresh CP, CP 9 DIC,  and 14 DIC in an ethidium bromide gel Figure 2
A) Amplified cDNA of liver (control), fresh CP, CP 9 DIC, 
and 14 DIC in an ethidium bromide gel. TTR amplifies as 371 
bp (top row), β-actin, used as internal standard amplifies at 
703 bp (bottom row). For each sample, lanes 1 through 5 
show amplification results for 15 to 35 cycles, with lanes cor-
responding to PCR products with 5 cycles of additional 
amplification (lane 1, 15; lanne 2,20, lane 3,25; lanne 4,30; 
lane 5, 35). B) Confocal images of choroid plexus epithelial 
cell monolayer 14 DIC. On the left, TTR is shown in green 
after incubation of the cells with anti-TTR and secondary 
antibody. Cell nuclei are shown in red (propidium iodide 
staining). No TTR staining was seen in control images (right 
side), when cells were incubated with secondary antibody 
only. C) TTR Western blot of liver (lanes 1 and 2), freshly 
isolated CP (lanes 3 and 4) and choroid plexus epithelial cells 
14 DIC (lanes 5 and 6). Samples without primary antibody 
served as controls (lanes 1, 3 and 5).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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Enzyme analysis
Two enzymes, alkaline phosphatase (AP; EC 3.1.3.1) and
γ-glutamyl transferase (γ-GT; EC 2.3.2.1), were used to
characterize cultured CPEC. Both membrane-bound
enzymes are present at the BCSFB in different species,
including pig, and have been previously used to character-
ize CP membrane preparations [26,27]. Activities were
determined for cultured CPEC at nine DIC, before serum
was removed from culture medium, and at 14 DIC, after
cells were fully differentiated. Measured enzyme activity
was compared to freshly isolated CPEC (0 DIC). AP activ-
ity (Figure 3A) decreased from 11.9 mU/mg down to 1.5
mU/mg and 1.4 mU/mg from 0 DIC to 9 DIC and 14 DIC,
resembling an 87.4% and 88.2% decrease compared to
activity measured after cell isolation. The reduction in γ-
GT (Figure 3B) was more gradual, with values decreasing
from 11.4 mU/mg to 9.5 mU/mg and 5.0 mU/mg from 0
DIC to 9 and 14 DIC, resembling a 16.7% and 56.1%
decrease after 14 DIC.
Cultured epithelial cell Cerebrospinal-Fluid Secretion
The high rate of CSF secretion in vivo is fuelled by the rapid
blood flow through the vascular supply to the plexus (5
ml/g/min), which is about tenfold higher than average
cerebral blood flow [28]. In vitro, CSF secretion was meas-
ured from cells grown on 6-well Transwell® filter systems.
FITC-dextran was added to the CSFB and secreted CSF vol-
ume (in μl/cm2) calculated as a function of FITC-dextran
concentration change.
Figure 4 shows the CSF volume secreted hourly by cul-
tured CPEC for up to 8 h. The volume of CSF secreted by
the monolayer increased in linear fashion, reaching a pla-
teau after 5 h of approximately 150 μl/cm2. No further
increase in CSF volume secreted per time interval was seen
thereafter. Using measurements made during the first 4 h
of linear CSF secretion, CSF production rates were meas-
ured to be 48.2 ± 4.6 μl/cm2/h. The volume of CSF pro-
duced in this model system is similar to results obtained
in previous studies [21], when a secretion rate of approxi-
mately 45 μl/cm2/h was measured over 4 h of incubation
using a slightly different calculation. In another study, sat-
uration of CSF production was reached after 6 h, with
12% of the basolateral chamber volume secreted into the
apical compartment [29]. In our studies, saturation was
reached after 5 h with an increase of approximately 15%
in apical volume. A possible reason for fluid secretion
reaching a plateau may be due to limitations imposed by
the culture system if there is an increase in proton concen-
tration in the basolateral chamber over time, which inhib-
its Na+/H+ exchange and thus fluid secretion (since the
basolateral fluid was not replaced) as described by
Hakvoort et al. [21].
Cultured CP Monolayer Transepithelial Resistance (TEER) 
Values
TEER values have been used extensively as a measure for
leakiness of cellular barriers. In the present study, CPEC
monolayers displayed TEER values in the range of 100 to
150  Ωcm2 and were judged confluent at values > 100
Ωcm2. Due to the anatomical location of the CP, there is
no data on TEER in vivo available for mammals and no
TEER information on lateral CP TEER for any species.
Fourth ventricle CP TEER measurements were carried out
in the bullfrog with values at approximately 170 Ωcm2
Choroid plexus epithelial cell secretion volumes after 14 DIC Figure 4
Choroid plexus epithelial cell secretion volumes after 14 
DIC. Measurements were taken every hour up to 8 h (means 
± SEM, n = 6).
Alkaline phosphatase (A) and γ-glutamyl-transferase (B) activ- ity in freshly isolated choroid plexus epithelial cells and cells  9 DIC and 14 DIC (means ± SEM, n = 6) Figure 3
Alkaline phosphatase (A) and γ-glutamyl-transferase (B) activ-
ity in freshly isolated choroid plexus epithelial cells and cells 
9 DIC and 14 DIC (means ± SEM, n = 6).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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[30]. Elasmobranch resistance values were measured with
values of 70 to 107 Ωcm2 [31]. In primary cultures of rat
CPEC, TEER values were in the range of 100–500 Ωcm2
[11,12]. Porcine CPEC models displayed resistance values
in the range of 100 to 170 Ωcm2 [14,21]. One group
reported TEER values exceeding 1500 Ωcm2, for cells
grown in serum-free medium, with higher values resulting
from the specific method of impedance analysis [22,32].
However, these resistance measurements were taken with
a different device to that used here. The values obtained in
the present study are equivalent to values of > 600 when
quantified by impedance analysis.
Permeability marker analysis
For cells of the BCSFB in vitro, the experimental conditions
influence cell differentiation, including tight junction (TJ)
expression. Even though in vitro models can be a good
tool for assessing epithelial transport, measurements tend
to overestimate in vivo drug movement and correlation
between both types of data is necessary. A wide range of
compounds has been used to characterize BBB and BCSFB
membranes, including the zero-permeability marker,
PEG-4000 (FDA, Biopharmaceutical Classification Sys-
tem: Guidance for Industry, 2000). In these experiments,
Papp  (apparent permeability coefficient) values ranged
from 4.56 ± 0.26 × 10-5 cm/s for smallest down to 1.42 ±
0.13 × 10-5 cm/s for largest molecules (Figure 5A). Nota-
bly, permeability decreased to a plateau at approximately
40 kDa, with Papp values for 42 kDa dextrans not signifi-
cantly different from Papp for 500 kDa dextrans.
Further evidence for CPEC TJ expression was gained from
comparing permeability across monolayers with intact or
opened TJs. One method of opening TJs is to remove free
calcium from surrounding medium. The transport of 5-
carboxyfluorescein (10 μM) in CPEC 14 DIC, was meas-
ured without and with 0.25% EDTA added to the
medium. Permeability of the paracellular marker was sig-
nificantly higher through monolayers with opened TJs,
with Papp values nearly doubling (Figure 5B).
ABC-Transport protein gene expression
Active excretion by ABC efflux transporters not only
removes endogenous metabolites and waste products
from the brain, but also limits uptake and penetration of
many therapeutic compounds [33]. Expression of ABC
transporters has been extensively studied at the BBB. With
delivery across the CP gaining importance and only lim-
ited information regarding ABC transporters at the BCSFB
available, further investigation into the role of these trans-
porters in CPEC is crucial. Two proteins contributing to
multidrug resistance are of particular importance due to
the large number and diversity of compounds trans-
ported: the MDR phenotype Pgp, part of the ABCB sub-
family, and Mrp1, part of the ABCC subfamily. Compared
to the BBB, relatively little is known about gene expression
of ABC-transport proteins Pgp and Mrp1 in CP and data
on CPEC Pgp and Mrp1 mRNA is only available for rat
[6,34].
Pgp and Mrp1 gene expression at the BCSFB was analyzed
on a qualitative and quantitative basis and the distribu-
tion and localization of both proteins to polarized CPEC
membranes determined. For Pgp and Mrp1 gene expres-
sion analyses, porcine RNA was isolated from fresh CP,
cultured CPEC 14 DIC and liver tissue (positive control).
To account for sample-to-sample variation, β-actin ampli-
fication was run simultaneously.
Comparative RT-PCR experiments from CP tissue and cul-
tured epithelial cell monolayers indicated the presence of
Pgp, thus corroborating recent findings in intact rodent
tissue [35]. Figure 6A shows the amplified 468 bp Pgp
DNA product and β-actin product at 703 bp visualized
under UV-light. Pgp was amplified for 50 cycles and β-
actin for 35 cycles. Liver mRNA was used as positive con-
trol. Fresh and cultured CPEC expressed Pgp mRNA at low
levels. Similar results, in terms of expression level, were
obtained in previous studies [6]. However, it must be
noted that the signal for Pgp was weaker in cultured epi-
thelial cells as compared to fresh tissue (Figure 6A). The
Pgp/β-actin density ratios amounted to 1.26 in liver tis-
sue, which was used as control, compared to 1.14 at fresh
Cp tissue, but only to 0.33 at cells at 14 DIC. The weaker
signal in cultured epithelial cells is comparable to the
reduction previously seen in freshly isolated and cultured
microvessel endothelial cells [16].
Figure 6B shows the amplified 436 bp Mrp1 DNA product
and β-actin product at 703 bp. Mrp1 was amplified for 50
cycles and β-actin (internal standard) for 35 cycles. Anal-
A) Apparent permeability coefficients of 5-carboxyfluores- cein and dextrans 0.4 kDa to 500 kDa (means ± SEM, n = 6) Figure 5
A) Apparent permeability coefficients of 5-carboxyfluores-
cein and dextrans 0.4 kDa to 500 kDa (means ± SEM, n = 6). 
B) Permeability of 5-carboxyfluorescein without and with 
open tight junctions by the addition of EDTA (means ± SEM, 
n = 6).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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ysis revealed Mrp1 mRNA expression in fresh and cultured
CPEC. Liver mRNA was again used as a positive control.
For a semi-quantitative analysis, Mrp1 was amplified at 30
cycles and mRNA of cultured CPEC 14 DIC was compared
to freshly isolated CPEC. After normalization to β-actin
RNA, there was no significant difference between Mrp1
gene expression in cultured CPEC 14 DIC and freshly iso-
lated CPEC (Figure 6B). The MRP1/β-actin density ratio in
liver tissue was 1.00, compared to 1.19 for fresh CP tissue
and 0.93 for cells 14 DIC.
Immunostaining confirmed the differences in Pgp and
Mrp1 expression: The monoclonal antibody C219 (Alexis,
Grünberg, FRG) was used as primary antibody for Pgp
immunofluorescence. The Pgp protein, stained green,
showed a subapical and possible intracellular localiza-
tion, rather than a clear membrane-associated distribu-
tion both in intact tissue and in cultured epithelial cells
(Figure 7A). This suggests that localization of Pgp in CP
may be different from that in other epithelial cells.
Mrp1 protein was also visualized in freshly isolated CP
and cultured CPEC (Figure 7B). Epithelial cells were
stained with MRPr1 antibody (Alexis, Grünberg, FRG),
previously shown to bind specifically to its antigen [36].
The image depicts a large single CP blood vessel, sur-
rounded by a single layer of epithelial cells. All epithelial
cell nuclei within the focal plane are shown in red. The
inside of CP blood vessels appears black. Mrp1 was clearly
present in CP epithelium. Staining was most intense
towards the basolateral, blood side of the epithelium.
Thus, Mrp1 is expressed and localized to the basolateral
membrane. Mrp1 expression was also analyzed in CPEC
14 DIC. Figure 7B, right side, shows one xy-section and a
digitally reassembled construct of 20 xy-sections taken at
1  μm intervals. As in fresh CP tissue, Mrp1 is highly
expressed in cultured CPEC, and is concentrated at the
basolateral membrane.
To further clarify the localization of Pgp in epithelial cells,
Western blots of Pgp with isolated membrane fractions
were performed. Apical and basolateral fractions were iso-
lated. Based on the activity of alkaline phosphatase and γ-
glutamyl transferase, the enrichment over homogenate of
apical (CSF oriented) membranes was 27.3 ± 0.8 fold and
27.7 ± 1.0, respectively. Western blot analysis showed that
Mrp1 was localized exclusively in the basolateral (blood
facing) membrane (Figure 8). For Pgp, Western blots of
these membrane fractions excluded basolateral localiza-
tion but a weak signal was found in apical membrane frac-
tions (Figure 8).
Functional studies with Pgp
Functional characterization of Pgp was carried out in
CPEC 14 DIC using the Pgp substrates rhodamine 123
and verapamil. Uptake of various concentrations of rhod-
amine 123 into CPEC 14 DIC cultured in 96-well plates
was measured and the effects of transport inhibitors with
known affinity for Pgp assessed.
A) Confocal images of choroid plexus epithelial cell monolay- ers (right side) and freshly isolated intact tissue (left side) Figure 7
A) Confocal images of choroid plexus epithelial cell monolay-
ers (right side) and freshly isolated intact tissue (left side). 
Pgp (immunostaining shown in green) is localized sub-apical 
(intracellular) rather than in apical membranes. B) Immunos-
taining of Mrp1 in 14 day-old cell monolayers (right side) and 
freshly isolated intact tissue (left side). Immunostaining 
(green) occurs predominantly in the abluminal (basolateral) 
side.
A) RT-PCR of Pgp (468 bp) and β-actin (703 bp); from left to  right: liver (lanes 1 and 2), fresh CP tissue (lanes 3 and 4) and  CPEC 14 DIC (lanes 5 and 6) Figure 6
A) RT-PCR of Pgp (468 bp) and β-actin (703 bp); from left to 
right: liver (lanes 1 and 2), fresh CP tissue (lanes 3 and 4) and 
CPEC 14 DIC (lanes 5 and 6). B) RT-PCR of Mrp1 (436 bp) 
and β-actin (703 bp) in CPEC 14 DIC (lanes 1 and 4), fresh 
CP tissue (lanes 2 and 5) and liver (lanes 3 and 6).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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The mainly intracellular localization of Pgp leaves room
for speculation as to if and how compounds are excluded
from CPEC. Should Pgp be inserted into the apical mem-
brane of the epithelium, Pgp substrates would be trans-
ported back into the medium. Concomitant incubation
with inhibitors would reduce efflux and lead to an
increase in cellular substrate uptake. If Pgp localized to
cytoplasmic vesicles, substrate would be trapped within
the cellular vesicles. Exocytosis of substrate-filled vesicles
would reduce substrate concentrations. Effects of inhibi-
tors on intracellular vesicularized Pgp would only alter
cellular concentrations if basolateral exocytosis occurs,
leading to an increase in cellular substrate concentrations.
To functionally characterize Pgp activity, cells were incu-
bated with 2 μM of rhodamine 123 for 1 hour with Pgp-
substrates or without (control). Proline was used as a sec-
ondary control. In cultured CPEC none of the effectors,
including cyclosporine-A (CSA) and its analog PSC883,
caused a significant alteration in 2 μM rhodamine 123
uptake over 1 h (Figure 9), suggesting that Pgp is not func-
tionally active in the membranes of this cell culture
model.
In addition to studies of rhodamine 123, the transport of
verapamil was measured in CP epithelial cells grown on
permeable filter supports. Permeability was determined
from apical to basolateral (a → b) and from the basola-
teral to the apical side (b → a) of cells. The transport of
verapamil across brain capillary endothelial cells was also
measured as a control. Contrary to capillary endothelial
cells, where a preferential net transport from the ablumi-
nal (al) to the luminal (l) compartment was seen (ratio al
→ l/l → al: 8.27; in presence of 10 μM Pgp blocker PSC-
833: 1.25), no preferred transport was observed in CP epi-
thelial cells in either apical (a) or basolateral direction (b)
(ratio a → b/b → a: 1.22). This result confirms the find-
ings with rhodamine 123 and makes it likely, that Pgp is
not functionally active in cultured CP cells (Table 2).
Functional studies with Mrp1
Secretion of the Mrp-substrate Fluorescein-Methotrexate
was analyzed in cultured CPEC and fully differentiated at
14 DIC. Thereby, transport of FL-MTX across CPEC grown
on Transwell®  filter systems was determined, allowing
direct access to the blood-facing side of CPEC. The meta-
bolic inhibitor NaCN reduced transport of 2 μM FL-MTX
from the apical to the basolateral compartment by more
than 50% (Figure 10a), as seen in ex vivo tissue [37]. Incu-
bation with organic anions leukotriene C4 (LTC4), MK571
and vinblastine significantly reduced FL-MTX transport
from apical to basolateral compartments.
Transport of 2 μM FL-MTX from basolateral to apical
chambers was not significantly different from apical to
basolateral secretion (Figure 10b). Incubation with other
organic anions, including p-aminohippuric acid and
probenecid did not significantly affect transport of FL-
MTX. Hence, FL-MTX transport from the apical to basola-
teral chambers was affected by inhibitors but not vice
versa. Regarding molecular and immunohistochemical
data, inhibitors NaCN, LTC4 and MK571 are most likely
targeting Mrp1, expressed at the basolateral membrane of
CPEC. Thus, it is likely that transport of FL-MTX was
reduced due to decreased efflux on Mrp1.
Uptake of 2 μM rhodamine 123 without (control) and with  substrates of ABC-transport proteins Figure 9
Uptake of 2 μM rhodamine 123 without (control) and with 
substrates of ABC-transport proteins. None of the com-
pounds showed a significant effect on uptake of the Pgp sub-
strate rhodamine 123 (CSA = cyclosporine A, PSC = PSC-
833; LTC4 = leucotriene C4; means ± SEM, n = 6).
Western blot of Mrp1 (left side; primary antibody MRPR1)  and Pgp (right side; primary antibody: Alexis C219) Figure 8
Western blot of Mrp1 (left side; primary antibody MRPR1) 
and Pgp (right side; primary antibody: Alexis C219). Left side: 
lane 1, apical CP membranes; lane 2, basolateral CP mem-
branes; Right side: lane 1, brain capillary endothelial cells (20 
μg); lane 2, basolateral choroid plexus epithelial cells mem-
branes (10 μg); lane 3, apical membrane (10 μg); lane 4, baso-
lateral membrane (25 μg); lane 5, apical membrane (25 μg).Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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Discussion
The goal of the present study was the development of a CP
epithelial cell culture model, which allows drug transport
from blood to CSF and vice versa to be studied in vitro.
Morphological and functional characterization of such a
model is an indispensable prerequisite to estimate its pre-
dictive character. It has been demonstrated that porcine
CP epithelium can be isolated and cultured, with cells
growing into intact monolayers, fully differentiating and
with properties resembling the tissue in vivo. Monolayers
were formed approximately at day 9 after plating, which
was faster than described previously [38] with monolayer
formation observed with rat CPECs at 12–14 days, but
similar to measurements of monolayer formation with rat
CPEC at day 8 [12]. In another study with CPECs from
sheep [39], optical confluence of cultured cells appeared
at days 2–3 after seeding, with TEER values significantly
increased between days 4 and 6 and a steady state TEER
value of 85 ± 9 Ωcm2 reached at day 8. In our system TEER
values of 100–150 Ωcm2were determined at confluence
with an apparent permeability coefficient of 5-carboxyflu-
orescein of 4.5 × 10-5 cm/s, whereas with sheep CPEC an
apparent permeability coefficient of [14C]sucrose of
approximately 0.8 × 10-5 cm/sec has been measured [39],
indicating a tighter monolayer. With rat CPEC monolay-
ers a similar permeability coefficient of sucrose of 0.7 ×
10-5 cm/sec was determined at day 8 [12].
The marker enzymes AP and γ-GT showed a decrease in
activity over culture time. However, enzymatic activity is
often reduced with in vitro preparations when compared
to tissue in vivo, as culture conditions and surrounding
environments differ. For example, reduced AP and γ-GT
activity was observed in primary brain capillary endothe-
lial cell (BCEC) cultures, with activity decreased during
cell proliferation and continuing low even after cells had
grown into a confluent monolayer and become fully dif-
ferentiated [40].
The most interesting aspect in the evaluation of the model
was the reduced function of the Mdr1-gene product, p-
glycoprotein. Recently, ABC-transporters and in particular
p-glycoprotein came in focus as one of the major defense
mechanisms of the blood brain barrier protecting the CNS
from xenobiotics and maintaining the well balanced
homeostasis inside the brain [41-44]. Pgp is also
expressed in CP epithelial cells [35,45]. A lack of Pgp func-
tion would be in contrast to other organs such as liver,
kidney, small intestine or blood brain barrier, where Pgp
is documented to play a major role in efflux of com-
pounds and/or transport into the blood stream. However,
in this cell culture model, no directed transport of the Pgp
A) Transport of fluorescein-methotrexate across cultured  choroid plexus epithelial cells (14 DIC) from the apical to the  basolateral side in absence and presence of modifiers of  organic anion transport expressed as a percentage of control  (means ± SEM, n = 6) Figure 10
A) Transport of fluorescein-methotrexate across cultured 
choroid plexus epithelial cells (14 DIC) from the apical to 
the basolateral side in absence and presence of modifiers of 
organic anion transport expressed as a percentage of control 
(means ± SEM, n = 6). B) Transport of fluorescein-meth-
otrexate across cultured choroid plexus epithelial cells from 
the basolateral to the apical side in absence and in presence 
of modifiers of organic anion transport. None of the com-
pounds showed a significant effect on Fl-MTX permeability 
(means ± SEM, n = 6).
Table 2: Permeability of verapamil across isolated brain capillary endothelial cells and isolated choroid plexus epithelial cells kept in 
monolayer cultures.
mean permeability coefficient (× 10-5cm/sec) ratio
Brain capillary endothelial cells luminal (l) → abluminal (al) 4.68 al → l/l → al (brain→blood/blood→brain) 8.27
abluminal → luminal 38.70
CP epithelial cells apical (a) → basolateral (b) 11.65 a → b/b → a (CSF→blood/blood→CSF) 1.22
basolateral → apical 9.55Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
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substrates, verapamil and rhodamine 123, was observed,
which is different from the permeability across capillary
endothelial cell monolayers.
There is no data comparing CPEC ABC-transporter expres-
sion in vivo and in vitro. With regard to the BBB, there is
one comparative study that investigated expression levels
in fresh brain and cultured BCEC [16]. Analysis of Pgp
and Mrp1 in whole-brain tissue, isolated brain capillaries
and cultured cells showed that gene expression levels var-
ied up to 7-fold after capillary isolation and that expres-
sion in cultured cells may be reduced up to 5-fold. The
study presented here is the first to provide data on Pgp and
Mrp1 mRNA expression in porcine CPEC, and first to
present comparative results for Mrp1 mRNA expression in
freshly isolated and cultured CPEC on a semi-quantitative
basis.
The downregulation of Pgp expression may depend on
the culture conditions. There are several alternative expla-
nations for a lack of Pgp functionality [33]. Besides Pgp
expression levels being too low to affect CP epithelial drug
secretion, the protein is not inserted into the membranes
of cultured CPEC at sufficiently high rates. Conversely,
Pgp might cluster in vesicles, which are not transported
and/or exocytosis does not function effectively in cultured
CPEC.
Our finding of a subapical or intracellular localization is
in accordance with the observation of previous investiga-
tors [35], who detected Pgp in 9- to 12-day-old choroid
plexus epithelial cells cultures from rat by indirect
immunofluorescence with a punctate or granular staining
pattern throughout the cytoplasm. A plasma membrane
expression pattern was only occasionally, but not uni-
formly, observed. Nevertheless, in that study functional
activity of Pgp could be demonstrated using paclitaxel and
Tc-sestamibi as substrates.
In vivo data concerning the functional role of Pgp at the
BCSFB are ambivalent: A recent trial with patients suffer-
ing from brain tumors showed that there was a trend
towards lower paclitaxel concentrations in CSF when
given together with tamoxifen [46]. The authors con-
cluded, that agents, which inhibit Pgp, such as tamoxifen,
may decrease CSF concentrations of Pgp substrates. How-
ever, from another study with intact choroid plexus tissue
from guinea pig showing that uptake of the Pgp substrate
ritonavir was not influenced by vinblastine, verapamil or
other HIV-protease inhibitors, it was concluded that Pgp
does not influence the disposition of that drug [47].
Therefore, the functional role of Pgp in intact choroid
plexus tissue remains to be clarified.
In contrast, Mrp1 was functionally active in cultured CP
cells. Comparative experiments using the model com-
pound FL-MTX, which is transported via a complex inter-
play of several transport proteins, revealed that these
complex processes are fully functional in cultured cells.
Results obtained in vitro mimicked the distribution
observed in vivo [37,48]. This finding is supported by stud-
ies in mice, showing an increased accumulation of the
Mrp1 substrate etoposide in CSF of animals lacking Mrp1
[49]. This indicates, that in CP epithelium Mrp1 may act
as a barrier for certain drugs coming from the blood.
Conclusion
We have established a model of primary choroid plexus
epithelial cells from pig brain, which allows the investiga-
tion of transport processes. It can be used as a reliable tool
for analysis of xenobiotic transport across the blood-cere-
brospinal fluid barrier. Expression of Pgp is down-regu-
lated in this model, whereas Mrp1 maintained expression
levels and functional activity. The predominantly intracel-
lular localization of Pgp parallels the findings in intact tis-
sue and raises the question about the functional role of
this protein in choroid plexus
Abbreviations
AP, alkaline phosphatase; BCEC, brain capillary endothe-
lial cells; BCSFB, blood-CSF barrier; CNS, central nervous
system, CP, choroid plexus; CSF, cerebrospinal fluid;
CPEC, choroid plexus epithelial cells; DIC, days in cul-
ture; γ-GT, gamma-Glutamyl-Transpeptidase; KRB, Krebs-
Ringer buffer; TEER, transepithelial electrical resistance;
TTR, transthyretin;
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
CB carried out the cell isolation, PCR-studies, enzymatic
characterisation, Western Blot experiments and fluid
secretion studies. VR performed the functional studies
with ABC transport proteins and permeability marker
analyses. GF conceived of the study, and participated in its
design and coordination. All authors read and approved
the final manuscript.
Acknowledgements
The study was supported by a research grant by the Foundation 3R Swit-
zerland
References
1. Spector R: Drug transport in the mammalian central nervous
system: multiple complex systems. A critical analysis and
commentary.  Pharmacology 2000, 60:58-73.
2. Spector R, Johanson CE: The mammalian choroid plexus.  Sci Am
1989, 261:68-74.Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
Page 13 of 14
(page number not for citation purposes)
3. Cserr HF: Physiology of the choroid plexus.  Physiol Rev 1971,
51:273-311.
4. Ghersi-Egea JF, Strazielle N: Brain drug delivery, drug metabo-
lism, and multidrug resistance at the choroid plexus.  Microsc
Res Tech 2001, 52:83-88.
5. el-Bacha RS, Minn A: Drug metabolizing enzymes in cerebrov-
ascular endothelial cells afford a metabolic protection to the
brain.  Cell Mol Biol 1999, 45:15-23.
6. Choudhuri S, Cherrington NJ, Li N, Klaassen CD: Constitutive
expression of various xenobiotic and endobiotic transporter
mRNAs in the choroid plexus of rats.  Drug Metab Dispos 2003,
31:1337-1345.
7. Lee G, Dallas S, Hong M, Bendayan R: Drug transporters in the
central nervous system: brain barriers and brain paren-
chyma considerations.  Pharmacol Rev 2001, 53:569-96.
8. Crook RB, Kasagami H, Prusiner SB: Culture and characteriza-
tion of epithelial cells from bovine choroid plexus.  J Neuro-
chem 1981, 37:845-854.
9. Mayer SE, Sanders-Bush E: Sodium-dependent antiporters in
choroid plexus epithelial cultures from rabbit.  J Neurochem
1993, 60:1308-1316.
10. Ramanathan VK, Hui AC, Brett CM, Giacomini KM: Primary cell
culture of the rabbit choroid plexus: an experimental system
to investigate membrane transport.  Pharm Res 1996,
13:952-956.
11. Southwell BR, Duan W, Alcorn D, Brack C, Richardson SJ, Kohrle J,
Schreiber G: Thyroxine transport to the brain: role of protein
synthesis by the choroid plexus.  Endocrinology 1993,
133:2116-2126.
12. Strazielle N, Ghersi-Egea JF: Demonstration of a coupled metab-
olism-efflux process at the choroid plexus as a mechanism of
brain protection toward xenobiotics.  J Neurosci 1999,
19:6275-6289.
13. Villalobos AR, Parmelee JT, Pritchard JB: Functional characteriza-
tion of choroid plexus epithelial cells in primary culture.  J
Pharmacol Exp Ther 1997, 282:1109-1116.
14. Gath U, Hakvoort A, Wegener J, Decker S, Galla HJ: Porcine
choroid plexus cells in culture: expression of polarized phe-
notype, maintenance of barrier properties and apical secre-
tion of CSF-components.  Eur J Cell Biol 1997, 74:68-78.
15. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. A laboratory man-
ual Cold Spring Harbor Laboratory Press; 1989. 
16. Török M, Huwyler J, Gutmann H, Fricker G, Drewe J: Modulation
of transendothelial permeability and expression of ATP-
binding cassette transporters in cultured brain capillary
endothelial cells by astrocytic factors and cell-culture condi-
tions.  Exp Brain Res 2003, 153:356-365.
17. D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczycy P, Kaplan JC:
Maximizing sensitivity and specificity of PCR by preamplifi-
cation heating.  Nucleic Acid Res 1991, 19:3749.
18. Bradford MA: Rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of
protein-dye binding.  Ana Biochem 1976, 72:248-254.
19. Caspers ML, Diglio CA: Expression of gamma-glutamyl-
transpeptidase in a transformed rat cerebral endothelial cell
line.  Biochim Biophys Acta 1984, 803:1-6.
20. Hilden SA, Johns CA, Guggino WB, Madias NE: Techniques for iso-
lation of brush-border and basolateral membrane vesicles
from dog kidney cortex.  Biochim Biophys Acta 1989, 983:77-81.
21. Hakvoort A, Haselbach M, Galla HJ: Active transport properties
of porcine choroid plexus cells in culture.  Brain Res 1998,
795:247-256.
22. Wegener J, Sieber M, Galla HJ: Impedance analysis of epithelial
and endothelial cell monolayers cultured on gold surfaces.  J
Biochem Biophys Meth 1996, 32:151-170.
23. Anderson J, Van Itallie CM: Tight junctions and the molecular
basis for regulation of paracellular permeability.  Am J Physiol
1995, 269:G467-475.
24. Stauder AJM, Dickson PW, Aldred AR, Schreiber G, Mendelsohn FA,
Hudson P: Synthesis of transthyretin (pre-albumin) mRNA in
choroid plexus epithelial cells, localized by in situ hybridiza-
tion in rat brain.  J Histochem Cytochem 1986, 34:949-952.
25. Archibald AL, Couperwhite S, Jiang ZH: The porcine TTR locus
maps to chromosome 6q.  Anim Genet 1996, 27:351-353.
26. De Bault LE, Mitro A: Species differences in the distribution of
gamma-glutamyl transpeptidase in choroid plexus of lateral
ventricle and microvessels of adjacent brain.  Histochem J 1994,
26:447-452.
27. Narisawa S, Hasegawa H, Watanabe K, Millan JL: Stage-specific
expression of alkaline phosphatase during neuronal develop-
ment in the mouse.  Dev Dyn 1994, 201:227-235.
28. Johanson CE: Ventricles and cerebrospinal fluid.  In Neuroscience
in Medicine Edited by: Conn P. Philadelphia: J.B. Lippincott Company;
1995:171-196. 
29. Hakvoort A, Haselbach M, Wegener J, Hoheisel D, Galla HJ: The
polarity of choroid plexus epithelial cells in vitro is improved
in serum free medium.  J Neurochem 1998, 71:1141-1150.
30. Saito Y, Wright EM: Bicarbonate transport across the frog
choroid plexus and its control by cyclic nucleotides.  J Physiol
1983, 336:635-648.
31. Villalobos AR, Miller DS, Renfro JL: Transepithelial organic anion
transport by shark choroid plexus.  Am J Physiol 2002,
282:R1308-1316.
32. Angelow S, Zeni P, Galla HJ: Usefulness and limitation of pri-
mary cultured porcine choroid plexus epithelial cells as an in
vitro model to study transport at the blood CSF barrier.  Adv
Drug Deliv Rev 2004, 56:1859-1873.
33. Begley DJ: ABC transporters and the blood-brain barrier.  Curr
Pharm Des 2004, 10:1295-312.
34. Nishino J, Suzuki H, Sugiyama D, Kitazawa T, Ito K, Hanano M, Sugi-
yama Y: Trans-epithelial transport of organic anions across
the choroid plexus: possible involvement of organic anion
transporter and multidrug resistance-associated protein.  J
Pharmacol Exp Ther 1999, 290:289-94.
35. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli
AC, Piwnica-Worms D: Choroid plexus epithelial expression of
MDR1 P glycoprotein and multidrug resistance-associated
protein contribute to the blood-cerebrospinal-fluid drug-
permeability barrier.  Proc Natl Acad Sci USA 1999, 96:3900-3905.
36. Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds
J, van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, van der Linden
M, de Vree JM, van der Valk P, Elferink RP, Borst P, Scheper RJ: Spe-
cific detection of multidrug resistance proteins MRP1,
MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel
of monoclonal antibodies.  Cancer Res 2000, 60:5269-5277.
37. Baehr CH, Fricker G, Miller DS: Fluorescein-Methotrexate
transport in dogfish shark (Squalus acanthias) choroid
plexus.  Am J Physiol Regul Integr Comp Physiol 2006, 291:R464-472.
38. Shen H, Keep RF, Hu Y, Smith DE: PEPT2 (Slc15a2)-mediated
unidirectional transport of cefadroxil from cerebrospinal
fluid into choroid plexus.  J Pharmacol Exp Ther 2005,
315:1101-1108.
39. Redzic ZB, Isakovic AJ, Misirlic Dencic ST, Popadic D, Segal MB: Une-
ven distribution of nucleoside transporters and intracellular
enzymatic degradation prevent transport of intact [14C]
adenosine across the sheep choroid plexus epithelium as a
monolayer in primary culture.  Cerebrospinal Fluid Res 2006, 3:4.
40. Fukushima H, Fujimoto M, Ide M: Quantitative detection of
blood-brain barrier-associated enzymes in cultured
endothelial cells of porcine brain microvessels.  In Vitro Cell Dev
Biol 1990, 26:612-620.
41. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL,
Melamed MR, Bertino JR: Multidrug-resistance gene (P-glyco-
protein) is expressed by endothelial cells at blood-brain bar-
rier sites.  Proc Natl Acad Sci USA 1989, 86:695-698.
42. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van
Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele
HP, et al.: Disruption of the mouse mdr1a P-glycoprotein gene
leads to a deficiency in the blood-brain barrier and to
increased sensitivity to drugs.  Cell 1994, 77:491-502.
43. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, Fricker
G: Xenobiotic transport across isolated brain microvessels
studied by confocal microscopy.  Mol Pharmacol 2000,
58:1357-1367.
44. Fricker G, Miller DS: Modulation of drug transporters at the
blood-brain barrier.  Pharmacology 2004, 70:169-76.
45. Gao B, Meier PJ: Organic anion transport across the choroid
plexus.  Microsc Res Tech 2001, 52:60-64.
46. Chen J, Balmaceda C, Bruce JN, Sisti MB, Huang M, Cheung YK, McK-
hann GM, Goodman RR, Fine RL: Tamoxifen paradoxically
decreases paclitaxel deposition into cerebrospinal fluid of
brain tumor patients.  J Neurooncol 2006, 76:85-92.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cerebrospinal Fluid Research 2006, 3:13 http://www.cerebrospinalfluidresearch.com/content/3/1/13
Page 14 of 14
(page number not for citation purposes)
47. Anthonypillai C, Sanderson RN, Gibbs JE, Thomas SA: The distribu-
tion of the HIV protease inhibitor, ritonavir, to the brain,
cerebrospinal fluid, and choroid plexuses of the guinea pig.  J
Pharmacol Exp Ther 2004, 308:912-920.
48. Breen CM, Sykes DB, Baehr C, Fricker G, Miller DS: Fluorescein-
methotrexate transport in rat choroid plexus analyzed using
confocal microscopy.  Am J Physiol Renal Physiol 2004,
287:F562-569.
49. Wijnholds J, deLange EC, Scheffer GL, van den Berg DJ, Mol CA, van
der Valk M, Schinkel AH, Scheper RJ, Breimer DD, Borst P: Multid-
rug resistance protein 1 protects the choroid plexus epithe-
lium and contributes to the blood-cerebrospinal fluid
barrier.  J Clin Invest 2000, 105:279-285.